Human Papillomavirus Genotype-Specific Persistence and Potential Risk Factors among Korean Women: Results from a 2-Year Follow-up Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose High-risk human papillomavirus (HPV) infection progression should be considered a critical factor for preventing cervical cancer, although most infections are transient and rarely persist. This study aimed to examine the specific types of HPV infections, their change patterns, and the potential risk factors among Korean women. Materials and Methods We included 4,588 women who visited hospitals in Busan and Suwon for cervical cancer screening, and 1,224 of these women attended a 2-year follow-up. Infection status was evaluated using HPV DNA testing (Hybrid Capture 2) and genotyping testing (Linear Array). Data regarding the potential risk factors for HPV infection were collected by trained nurses using structured questionnaires. Results Among the 1,224 women (mean age, 47 years), 105 women (8.6%) were HPV-positive at baseline. HPV infections had been cleared among 92 women (87.6%) within 2 years. Only 13 infections (12.4%) were remained, and the 10 cases of them are high-risk HPV types including genotype 33, 45, 16, 35, and 52. Among women who were negative at baseline, the HPV incidence was 4.8%. The HPV incidence was marginally associated with having multiple sexual partners (odds ratio, 2.0; 95% confidence interval, 1.0 to 3.9), although it was not significantly associated with HPV persistence. Conclusion Most HPV infections (88%) among Korean women were cleared within 2 years, with only a small number of persistent infections. The persistent HPV genotypes were different in our study, compared to those from previous studies. Having multiple sexual partners was associated with acquiring a HPV infection, but not with persistence.
Abstract
Purpose High-risk human papillomavirus (HPV) infection progression should be considered a critical factor for preventing cervical cancer, although most infections are transient and rarely persist. This study aimed to examine the specific types of HPV infections, their change patterns, and the potential risk factors among Korean women. Materials and Methods We included 4,588 women who visited hospitals in Busan and Suwon for cervical cancer screening, and 1,224 of these women attended a 2-year follow-up. Infection status was evaluated using HPV DNA testing (Hybrid Capture 2) and genotyping testing (Linear Array). Data regarding the potential risk factors for HPV infection were collected by trained nurses using structured questionnaires. Results Among the 1,224 women (mean age, 47 years), 105 women (8.6%) were HPV-positive at baseline. HPV infections had been cleared among 92 women (87.6%) within 2 years. Only 13 infections (12.4%) were remained, and the 10 cases of them are high-risk HPV types including genotype 33, 45, 16, 35, and 52. Among women who were negative at baseline, the HPV incidence was 4.8%. The HPV incidence was marginally associated with having multiple sexual partners (odds ratio, 2.0; 95% confidence interval, 1.0 to 3.9), although it was not significantly associated with HPV persistence. Conclusion Most HPV infections (88%) among Korean women were cleared within 2 years, with only a small number of persistent infections. The persistent HPV genotypes were different in our study, compared to those from previous studies. Having multiple sexual partners was associated with acquiring a HPV infection, but not with persistence.
참고문헌 (30)
- Clifford G, "Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases", Vaccine, 24(Suppl 3), pp.S3 (2006), 26~S3[DOI]
- Peto J, "Cervical HPV infection and neoplasia in a large populationbased prospective study: the Manchester cohort", Br J Cancer, 91, pp.942~953 (2004)[DOI]
- Munoz N, "Chapter 1: HPV in the etiology of human cancer", Vaccine, 24(Suppl 3), pp.S3 (2006), 1~S3[DOI]
- Kim J, "Human papillomavirus genotypes and cofactors causing cervical intraepithelial neoplasia and cervical cancer in Korean women", Int J Gynecol Cancer, 22, pp.1570~1576 (2012)
- Bosch FX, "Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia", Vaccine, 26(Suppl 10), pp.K1~K16 (2008)[DOI]
- Castellsague X, "Natural history and epidemiology of HPV infection and cervical cancer", Gynecol Oncol, 110(3 Suppl 2), pp.S4~S7 (2008)[DOI]
- Syrjanen S, "Age-specific incidence and clearance of high-risk human papillomavirus infections in women in the former Soviet Union", Int J STD AIDS, 16, pp.217~223 (2005)[DOI]
- Oh JK, "Acquisition of new infection and clearance of type-specific human papillomavirus infections in female students in Busan, South Korea: a follow-up study", BMC Infect Dis, 8, pp.13~ (2008)[DOI]
- Rosa MI, "Persistence and clearance of human papillomavirus infection: a prospective cohort study", Am J Obstet Gynecol, 199, pp.617.e1~617.e7 (2008)[DOI]
- Ralston Howe E, "Type-specific prevalence and persistence of human papillomavirus in women in the United States who are referred for typing as a component of cervical cancer screening", Am J Obstet Gynecol, 200, pp.245~ (2009)
- Louvanto K, "Genotype-specific persistence of genital human papillomavirus (HPV) infections in women followed for 6 years in the Finnish Family HPV Study", J Infect Dis, 202, pp.436~444 (2010)[DOI]
- Nielsen A, "Persistence of high-risk human papillomavirus infection in a populationbased cohort of Danish women", J Med Virol, 82, pp.616~623 (2010)[DOI]
- Ye J, "Short-term typespecific HPV persistence and its predictors in an asymptomatic general female population in Zhejiang, China", Int J Gynaecol Obstet, 110, pp.217~222 (2010)[DOI]
- Marks M, "Combined oral contraceptive use increases HPV persistence but not new HPV detection in a cohort of women from Thailand", J Infect Dis, 204, pp.1505~1513 (2011)[DOI]
- Miranda PM, "Persistence or clearance of human papillomavirus infections in women in Ouro Preto, Brazil", Biomed Res Int, 2013, pp.578276~ (2013)
- Sammarco ML, "Type-specific persistence and associated risk factors of human papillomavirus infections in women living in central Italy", Eur J Obstet Gynecol Reprod Biol, 168, pp.222~226 (2013)[DOI]
- Schmeink CE, "Prospective follow-up of 2,065 young unscreened women to study human papillomavirus incidence and clearance", Int J Cancer, 133, pp.172~181 (2013)[DOI]
- Bae, Jeong-Hoon, "Human Papillomavirus (HPV) Type Distribution in Korean Women: A Meta-Analysis", Journal of Microbiology and Biotechnology, 18(4), pp.788~794 (2008), 한국미생물·생명공학회
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012", Cancer Research and Treatment, 47(2), pp.127~141 (2015), 대한암학회[DOI]
- Oh JK, "Prevalence of human papillomavirus and Chlamydia trachomatis infection among women attending cervical cancer screening in the Republic of Korea", Eur J Cancer Prev, 18, pp.56~61 (2009)[DOI]
- Stensen S, "Factors associated with type-specific persistence of high-risk human papillomavirus infection: a population-based study", Int J Cancer, 138, pp.361~368 (2016)[DOI]
- Schmeink CE, "Human papillomavirus persistence in young unscreened women, a prospective cohort study", PLoS One, 6, pp.e27937~ (2011)[DOI]
- Mollers M, "Prevalence, incidence and persistence of genital HPV infections in a large cohort of sexually active young women in the Netherlands", Vaccine, 31, pp.394~401 (2013)[DOI]
- Moscicki AB, "Updating the natural history of human papillomavirus and anogenital cancers", Vaccine, 30(Suppl 5), pp.F24~F33 (2012)[DOI]
- Syrjanen S, "Factors predicting persistence of high-risk human papillomavirus (HPV) infections in women prospectively followed-up in three New Independent States (NIS) of the former Soviet Union", Eur J Gynaecol Oncol, 26, pp.491~498 (2005)
- Castellsague X, "Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners", N Engl J Med, 346, pp.1105~1112 (2002)[DOI]
- International Collaboration of Epidemiological Studies of Cervical Cancer, "Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies", Cancer Epidemiol Biomarkers Prev, 18, pp.1060~1069 (2009)[DOI]
- Moscicki AB, "Chapter 5: Updating the natural history of HPV and anogenital cancer", Vaccine, 24(Suppl 3), pp.S3 (2006), 42~S3[DOI]
- Gravitt PE, "A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study", Cancer Epidemiol Biomarkers Prev, 17, pp.1248~1254 (2008)[DOI]
- Cook DA, "Comparison of the Roche cobas(R) 4800 and Digene Hybrid Capture(R) 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial", BMC Cancer, 15, pp.968~ (2015)[DOI]